Paper3944769
Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.
van Crugten J and 3 others. J Pharmacol Exp Ther, 1986. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs. Papers, record 3944769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3944769
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cephalexin | Major topic |
| Cephalothin | Major topic |
| Cimetidine | Major topic |
| Kidney | Major topic |
| Ranitidine | Major topic |
| Adult | |
| Drug Interactions | |
| Humans | |
| Kinetics | |
| Male | |
| Metabolic Clearance Rate |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30845766 | Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/30845766 | PubMed |
| 29236753 | Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine. | PLoS One | 2017 | https://conductscience.org/library/papers/29236753 | PubMed |
| 28210973 | Renal Drug Transporters and Drug Interactions. | Clin Pharmacokinet | 2017 | https://conductscience.org/library/papers/28210973 | PubMed |
| 27800573 | Pharmacokinetic Modeling and Monte Carlo Simulation to Predict Interindividual Variability in Human Exposure to Oseltamivir and Its Active Metabolite, Ro 64-0802. | AAPS J | 2017 | https://conductscience.org/library/papers/27800573 | PubMed |
| 26597253 | The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin. | Clin Pharmacokinet | 2016 | https://conductscience.org/library/papers/26597253 | PubMed |
| 26507723 | The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers. | Clin Pharmacokinet | 2016 | https://conductscience.org/library/papers/26507723 | PubMed |
| 12543679 | Effects of organic anion, organic cation, and dipeptide transport inhibitors on cefdinir in the isolated perfused rat kidney. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12543679 | PubMed |
| 11796358 | Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11796358 | PubMed |
| 10606839 | Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide. | Br J Clin Pharmacol | 2000 | https://conductscience.org/library/papers/10606839 | PubMed |
| 9592621 | Drug interactions at the renal level. Implications for drug development. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9592621 | PubMed |
| 8415403 | Stereoselective interactions of organic cations with the organic cation transporter in OK cells. | Pharm Res | 1993 | https://conductscience.org/library/papers/8415403 | PubMed |
| 3803421 | Lack of inhibition of tolbutamide hydroxylation by cimetidine in man. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3803421 | PubMed |
| 3680506 | Human placental transport of cimetidine. | J Clin Invest | 1987 | https://conductscience.org/library/papers/3680506 | PubMed |
| 3593625 | Reduction of metformin renal tubular secretion by cimetidine in man. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3593625 | PubMed |
| 3582467 | Inhibition and induction of metronidazole and antipyrine metabolism. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3582467 | PubMed |
| 3301148 | Pharmacokinetic interactions of cimetidine 1987. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3301148 | PubMed |
| 3220096 | Lack of effect of cimetidine on the pharmacokinetics and metabolism of a single oral dose of metronidazole. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3220096 | PubMed |
| 3072557 | Renal transport of drugs: an overview of methodology with application to cimetidine. | Pharm Res | 1988 | https://conductscience.org/library/papers/3072557 | PubMed |
| 2961569 | Interaction of cimetidine with bisoprolol. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/2961569 | PubMed |
| 2889461 | The effect of famotidine on renal function in patients with renal insufficiency. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/2889461 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3944769
GET https://conductscience.org/api/papers/v1/3944769/cited_by?page=2